Chapter 20 — Further Reading

One structural note before the list. Almost everything canonical for this chapter is free. HCPCS Level II is a CMS product, and unlike Chapter 13's CPT there is no licensing barrier between you and the primary source. If you take one habit from this chapter, take the habit of reading the actual file.

Tier 1 — Verified canonical sources

The HCPCS Level II code set, CMS. Free, downloadable, updated quarterly. The complete set of codes and descriptors. The descriptors are the whole of §20.3 — every units question in this chapter is answered by reading one.

The quarterly HCPCS update files, CMS. Additions, revisions, and terminations. §20.1's warning is about these, and subscribing to or calendaring them is the entire remedy.

CMS guidance on the JW and JZ modifiers, including which drugs and which container types they apply to and the documentation expected. Read this rather than any summary, including this one — the requirements have been clarified more than once.

The Medicare Part B drug average sales price files, CMS. Free, published quarterly. What separately payable drugs actually pay. §20.3's pricing discussion is a summary of this file's methodology, and a practice comparing acquisition cost to allowed amount is comparing against this.

Medicare Claims Processing Manual (Publication 100-04), Chapter 17 — drugs and biologicals, including units, waste, and the payment methodology.

Medicare Claims Processing Manual (Publication 100-04), Chapter 20 — durable medical equipment, prosthetics, orthotics, and supplies.

Medicare Program Integrity Manual guidance on DMEPOS documentation, including the written order requirements, proof of delivery, and the item-specific documentation lists. This is where §20.5's "read the policy and extract the required facts" actually happens.

DMEPOS supplier standards and enrollment requirements, CMS. The list Case Study 2's practice did not know applied to it. Short, specific, and verified.

Local coverage determinations and their associated policy articles for DMEPOS items. Chapter 22 covers what these are; for equipment they are the operative document, and they name the facts the record must contain.

CMS ambulance guidance, including the origin and destination modifier definitions and the coverage requirements. §20.2's table is a summary of a published list.

Payer requirements for NDC reporting, including required format, unit-of-measure qualifiers, and quantity conventions. Every payer that requires NDCs publishes its rules, and §20.8's four rejection causes are all addressed in them.

The National Drug Code Directory, FDA. Free. Where NDCs come from and how they are structured.

OIG Work Plan and reports on Part B drug billing, drug waste, and DMEPOS. DMEPOS has been a standing item for as long as the Work Plan has existed, and the reports describe the specific findings Case Study 2 is built from.

Tier 2 — Attributed, specifics unverified

AAPC and AHIMA material on HCPCS Level II, particularly on units and on the JW/JZ distinction. Both publish free content, and units arithmetic benefits from a second explanation.

Specialty society guidance on drug billing — oncology, rheumatology, ophthalmology, and allergy/immunology societies all publish practical material, and it is generally better than general coding material because it works from the drugs those specialties actually administer.

Infusion and oncology pharmacy literature on vial size, waste, and dose rounding. The clinical half of §20.4's conversation, and it explains why single-dose containers exist in the sizes they do.

Practice management literature on in-office dispensing — the business case, the compliance overhead, and the break-even analysis. Directly relevant to Case Study 2's closing point about fixed costs.

Published analyses of DMEPOS improper payment rates and their causes.

Compliance material on charge master maintenance for supply and drug lines. §20.10's surgical tray and §20.1's terminated codes are both charge master problems, and Chapter 23 §23.9 returns to it.

Tier 3 — Illustrative and constructed

All the units arithmetic in §20.3 and §20.4, including the methylprednisolone table and the 100 mg / 75 mg / "per 25 mg" exercise.

The procedure note excerpt in §20.3's 📋 Read the Chart.

Case Study 1 in its entirety — the practice, the written waste policy, the three years, and the purchasing-record reconciliation. Constructed; the detection method is real and available to you.

Case Study 2 in its entirety — the orthopedic practice, the braces, the eighteen months, and the supplier audit. Constructed; DMEPOS's improper payment rates and the "orders present, records empty" finding are documented.

Account 10-4471's J1030 analysis in §20.4, including the JZ conclusion.

Three things worth doing

Download the HCPCS Level II file and look up one drug you bill. Read the descriptor's dosage. Then compute the units for the doses your practice actually gives. If the arithmetic surprises you, you have found something, and you found it in ten minutes with a free file.

Then run Case Study 1's reconciliation: total units billed for one high-volume drug over a quarter, against total units purchased over the same quarter. No charts, both numbers already exist, and it finds an error class no chart review will surface.

And if your organization dispenses anything at all — braces, boots, slings, supplies — find out what enrollment it requires. One question. Case Study 2 is eighteen months of not asking it.